| SC 13D/A | 2024-03-05 | Weiss Asset Management LP | Theravance Biopharma, Inc. | - | - | EDGAR |
| SC 13G | 2024-02-14 | Irenic Capital Management LP | Theravance Biopharma, Inc. | 2,760,948 | 5.5% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Theravance Biopharma, Inc. | 3,489,262 | 7.0% | EDGAR |
| SC 13G/A | 2024-02-08 | BlackRock Inc. | Theravance Biopharma, Inc. | 4,584,596 | 9.2% | EDGAR |
| SC 13D/A | 2023-08-14 | Weiss Asset Management LP | Theravance Biopharma, Inc. | - | - | EDGAR |
| SC 13G/A | 2023-07-10 | BAUPOST GROUP LLC/MA | Theravance Biopharma, Inc. | 7,419,226 | 12.8% | EDGAR |
| SC 13D | 2023-04-12 | Weiss Asset Management LP | Theravance Biopharma, Inc. | - | - | EDGAR |
| SC 13G/A | 2023-02-14 | ORBIMED ADVISORS LLC | Theravance Biopharma, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Madison Avenue Partners, LP | Theravance Biopharma, Inc. | 7,012,226 | 10.4% | EDGAR |
| SC 13G/A | 2023-02-13 | BAUPOST GROUP LLC/MA | Theravance Biopharma, Inc. | 11,419,226 | 17.0% | EDGAR |
| SC 13G/A | 2023-02-10 | BlackRock Inc. | Theravance Biopharma, Inc. | 5,329,830 | 7.9% | EDGAR |
| SC 13G/A | 2023-02-10 | Weiss Asset Management LP | Theravance Biopharma, Inc. | 7,457,060 | 11.1% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Theravance Biopharma, Inc. | 5,558,839 | 8.2% | EDGAR |
| SC 13G | 2023-01-30 | BARCLAYS PLC | Theravance Biopharma, Inc. | 3,371,298 | 5.0% | EDGAR |
| SC 13D/A | 2022-09-20 | GSK PLC | Theravance Biopharma, Inc. | - | 0.0% | EDGAR |
| SC 13D/A | 2022-08-03 | GSK PLC | Theravance Biopharma, Inc. | 9,644,807 | 12.7% | EDGAR |
| SC 13G | 2022-06-16 | Weiss Asset Management LP | Theravance Biopharma, Inc. | 6,157,360 | 8.1% | EDGAR |
| SC 13G | 2022-04-21 | ODRE 2005 SLU | Theravance Biopharma, Inc. | 4,108,318 | 5.5% | EDGAR |
| SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Theravance Biopharma, Inc. | 145,100 | 0.2% | EDGAR |
| SC 13G/A | 2022-02-14 | Madison Avenue Partners, LP | Theravance Biopharma, Inc. | 6,648,025 | 9.0% | EDGAR |